EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 / Numéro 3 (Mars 2018) Med Sci (Paris), 34 3 (2018) 223-230 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, Numéro 3, Mars 2018
Page(s) 223 - 230
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20183403010
Publié en ligne 16 mars 2018
  1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37 : 614-36. [CrossRef] [PubMed] [Google Scholar]
  2. Brondello JM, Prieur A, Philipot D, et al. La sénescence cellulaire : un nouveau mythe de Janus? Med Sci (Paris) 2012; 28 : 288-96. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Pluquet O, Pourtier A, Abbadie C. The unfolded protein response and cellular senescence. A review in the theme: cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. Am J Physiol Cell Physiol 2014; 308 : C415-25. [CrossRef] [PubMed] [Google Scholar]
  4. Abbadie C, Pluquet O, Pourtier A. Epithelial cell senescence: an adaptive response to precarcinogenic stresses? Cell Mol Life Sci 2017; 74 : 4471-509. [CrossRef] [PubMed] [Google Scholar]
  5. Yang Q. Cellular senescence, telomere recombination and maintenance. Cytogenet Genome Res 2008; 122 : 211-8. [CrossRef] [PubMed] [Google Scholar]
  6. Vurusaner B, Poli G, Basaga H. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med 2012; 52 : 7-18. [CrossRef] [PubMed] [Google Scholar]
  7. Nassour J, Martien S, Martin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun 2016; 7 : 10399. [CrossRef] [PubMed] [Google Scholar]
  8. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37 : 961-76. [CrossRef] [PubMed] [Google Scholar]
  9. Narita M, Nunez S, Heard E, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113 : 703-16. [CrossRef] [PubMed] [Google Scholar]
  10. Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 2015; 21 : 1424-35. [CrossRef] [PubMed] [Google Scholar]
  11. He S, Sharpless NE. Senescence in Health and Disease. Cell 2017; 169 : 1000-11. [CrossRef] [PubMed] [Google Scholar]
  12. Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 2016; 530 : 184-9. [CrossRef] [PubMed] [Google Scholar]
  13. Michaloglou C, Vredeveld LC, Mooi WJ, Peeper DS. BRAF(E600) in benign and malignant human tumours. Oncogene 2008; 27 : 877-95. [Google Scholar]
  14. Zacarias-Fluck MF, Morancho B, Vicario R, et al. Effect of cellular senescence on the growth of HER2-positive breast cancers. J Natl Cancer Inst 2015; 105-7. [Google Scholar]
  15. Ouellette MM, Wright WE, Shay JW. Targeting telomerase-expressing cancer cells. J Cell Mol Med 2011; 15 : 1433-42. [CrossRef] [PubMed] [Google Scholar]
  16. Rossiello F, Herbig U, Longhese MP, et al. Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing. Curr Opin Genet Dev 2014; 26 : 89-95. [CrossRef] [PubMed] [Google Scholar]
  17. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114 : 1299-307. [CrossRef] [PubMed] [Google Scholar]
  18. Gosselin K, Martien S, Pourtier A, et al. Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res 2009; 69 : 7917-25. [Google Scholar]
  19. Martin N, Salazar-Cardozo C, Vercamer C, et al. Identification of a gene signature of a pre-transformation process by senescence evasion in normal human epidermal keratinocytes. Mol Cancer 2014; 13 : 151. [CrossRef] [PubMed] [Google Scholar]
  20. Malaquin N, Vercamer C, Bouali F, et al. Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis. PLoS One 2013; 8 : e63607. [CrossRef] [PubMed] [Google Scholar]
  21. Romanov SR, Kozakiewicz BK, Holst CR, et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001; 409 : 633-7. [CrossRef] [PubMed] [Google Scholar]
  22. Deruy E, Nassour J, Martin N, et al. Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion. Cell Death Dis 2014; 5 : e1577. [CrossRef] [PubMed] [Google Scholar]
  23. De Carne Trecesson S, Guillemin Y, Belanger A, et al. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins. J Biol Chem 2011; 286 : 12825-38. [CrossRef] [PubMed] [Google Scholar]
  24. Feijoo P, Terradas M, Soler D, et al. Breast primary epithelial cells that escape p16-dependent stasis enter a telomere-driven crisis state. Breast Cancer Res 2016; 18 : 7. [CrossRef] [PubMed] [Google Scholar]
  25. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436 : 720-4. [CrossRef] [PubMed] [Google Scholar]
  26. Choi J, Shendrik I, Peacocke M, et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 2000; 56 : 160-6. [Google Scholar]
  27. Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444 : 638-42. [CrossRef] [PubMed] [Google Scholar]
  28. Malaquin N, Martinez A, Rodier F. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype. Exp Gerontol 2016; 82 : 39-49. [CrossRef] [PubMed] [Google Scholar]
  29. Mavrogonatou E, Pratsinis H, Papadopoulou A, et al. Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis. Matrix Biol 2017. Oct 21. pii: S0945-053X(17)30296-2. doi: 10.1016/j. matbio.2017.10.004. [Google Scholar]
  30. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9 : 81-94. [CrossRef] [PubMed] [Google Scholar]
  31. Ruhland MK, Loza AJ, Capietto AH, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun 2016; 7 : 11762. [CrossRef] [PubMed] [Google Scholar]
  32. Toso A, Di Mitri D, Alimonti A. Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: a way to reactivate the antitumor immunity. Oncoimmunology 2015; 4 : e994380. [CrossRef] [PubMed] [Google Scholar]
  33. Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010; 102 : 1536-46. [CrossRef] [PubMed] [Google Scholar]
  34. Kirkland JL, Tchkonia T. Cellular senescence: a translational perspective. EBioMedicine 2017; 21 : 21-8. [CrossRef] [PubMed] [Google Scholar]
  35. Mosieniak G, Sliwinska MA, Alster O, et al. Polyploidy formation in doxorubicin-treated cancer cells can favor escape from senescence. Neoplasia 2015; 17 : 882-93. [Google Scholar]
  36. Wang Q, Wu PC, Dong DZ, et al. Polyploidy road to therapy-induced cellular senescence and escape. Int J Cancer 2013; 132 : 1505-15. [CrossRef] [PubMed] [Google Scholar]
  37. Jonchere B, Vetillard A, Toutain B, et al. Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1. Oncotarget 2015; 6 : 409-26. [CrossRef] [PubMed] [Google Scholar]
  38. Achuthan S, Santhoshkumar TR, Prabhakar J, et al. Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J Biol Chem 2011; 286 : 37813-29. [CrossRef] [PubMed] [Google Scholar]
  39. Simova J, Sapega O, Imrichova T, et al. Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines. Oncotarget 2016; 7 : 54952-64. [CrossRef] [PubMed] [Google Scholar]
  40. Tato-Costa J, Casimiro S, Pacheco T, et al. Therapy-induced cellular senescence induces epithelial-to-mesenchymal transition and increases invasiveness in rectal cancer. Clin Colorectal Cancer 2016; 15 : 170-8-e3. [CrossRef] [PubMed] [Google Scholar]
  41. Londono-Vallejo A, Lenain C, Gilson E. Cibler les télomères pour forcer les cellules cancéreuses à rentrer en sénescence. Med Sci (Paris) 2008; 24 : 383-9. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  42. Bilsland AE, Cairney CJ, Keith WN. Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives. J Cell Mol Med 2011; 15 : 179-86. [CrossRef] [PubMed] [Google Scholar]
  43. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 2015; 14 : 644-58. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.